Clinical Trial Update: PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for PACCE evaluating panitumumab in advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2010-09-14